Brussels, 22 June 2023 - EuropaBio is pleased to announce that bioMérieux has joined the association as Corporate Member.
bioMérieux is a family-owned biotechnology company founded in France. Since 1963, it has been at the forefront of ground-breaking advancements in the field of in vitro diagnostics, making significant contributions to improving public health worldwide. bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.
As a world leader in the field of industrial microbiological control, bioMérieux provides diagnostic solutions that detect pathogens and identify microorganisms responsible for contamination at all steps of the manufacturing process as well as within the manufacturing environment in food, pharmaceutical and cosmetic products.
With a partner-first approach to Pharmaceutical Quality Control, the bioMérieux’s experts deliver an integrated offer that easily adapts to facilities, products, and processes, allowing key industry players to provide critical therapies quickly and safely to patients.
EuropaBio Director-General Dr. Claire Skentelbery said “bioMérieux is a valued new member of the EuropaBio community. It reflects Europe’s critical strength and depth behind delivering innovative healthcare. We look forward to their expertise within our work across members within the Healthcare Council and Biomanufacturing Platform.”
bioMérieux (Pharma Quality Control business) Senior VP EMEA Nelly Dumont added “We are very pleased to become a corporate member of EuropaBio's Healthcare Council and Biomanufacturing Platform. Our primary focus is reinforcing the crucial role of quality control in the development and manufacturing of innovative medicine, prioritizing patient safety. Additionally, we aim to establish a robust network with European stakeholders, actively collaborating to strengthen the biotechnology industry in Europe.”